Head-to-head

Noom Med vs Gala GLP-1

Compared on semaglutide across the eight dimensions this database records. They differ on 5 of those eight. Gala GLP-1 is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.

The short answer

Noom Med is $199 a month all-in for semaglutide; Gala GLP-1 is $179. Over twelve months that is $2,388 against $2,148. Value Scores are 73.1 and 75.9 out of 100.

Semaglutide

Plan pages: Noom Med plans · Gala GLP-1 plans

At 2.4 mg/week, Noom Med is $199 a month all-in and Gala GLP-1 is $179 — $20 apart, or $240 across a year. Over twelve months the totals are $2,388 (billed monthly) and $2,148 (billed monthly).

Noom Med charges a flat $199 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.

Gala GLP-1 charges a flat $179 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.

0.250.511.72.4mg/week$199$199$199$199$199
Noom Med in petrol against Gala GLP-1 in graphite — all-in monthly semaglutide cost at each dose. Second line: Gala GLP-1.
All-in monthly semaglutide cost at each published dose, with each program's rank among everyone publishing at that dose
DoseNoom MedRankGala GLP-1RankCheaper
0.25 mg$19917/32$17914/32Gala GLP-1 by $20
0.5 mg$19912/21$1799/21Gala GLP-1 by $20
1 mg$19912/21$1799/21Gala GLP-1 by $20
1.7 mg$19912/21$1799/21Gala GLP-1 by $20
2.4 mg$19914/29$17911/29Gala GLP-1 by $20

Gala GLP-1 is cheaper at every dose where both publish a price, so the lead does not change as you titrate.

Across the 29 programs this database can rank on semaglutide, Noom Med sits 10 of 29 on all-in monthly cost and Gala GLP-1 sits 8. There is 1 other program priced between them. The field median is $249 and the floor is $129, so both sit below the median. Noom Med is $70 above the cheapest semaglutide program on record. Gala GLP-1 is $50 above the cheapest semaglutide program on record.

NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — Noom Med undercuts it by $150, Gala GLP-1 by $170. Compounded products are not FDA approved; insurance can reverse that comparison.

Published semaglutide rates per month on each plan term
Plan termNoom MedGala GLP-1Cheaper
Month to month$199$179Gala GLP-1 by $20
3-month term$199only Gala GLP-1 publishes this term
Twelve months of semaglutide if you settled at each dose
Settled doseNoom MedGala GLP-1Difference
0.25 mg$2,388$2,148$240 apart
0.5 mg$2,388$2,148$240 apart
1 mg$2,388$2,148$240 apart
1.7 mg$2,388$2,148$240 apart
2.4 mg$2,388$2,148$240 apart

Noom Med publishes no rate for 3-month term, 6-month term, 12-month term; Gala GLP-1 publishes none for 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.

A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $2,388 on Noom Med and $2,148 on Gala GLP-1. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.

Value Scores are 73.1 for Noom Med and 75.9 for Gala GLP-1, against a semaglutide category floor of $129. Gala GLP-1 leads by 2.8 points, driven mostly by price.

Semaglutide Value Score components
ProgramPrice /70Evidence /15Dose /10Membership /5Total /100
Noom Med45.412.810573.1
Gala GLP-150.510.510575.9

Where the two programs differ

All-in monthly

Gala GLP-1 is cheaper month to month — $179 against $199, a gap of $20 every month, or $240 across a year if both rates hold.

Cancellation terms

Cancellation differs: Noom Med states Per plan terms, while Gala GLP-1 states Per provider terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.

Commitment

Noom Med asks for Program-based; Gala GLP-1 asks for 3-month plan or standard monthly; confirm exact terms at enrollment. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.

Evidence status

The two prices are not equally well evidenced. Noom Med's figure is provider-stated and Gala GLP-1's is reported. Noom Med rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.

Twelve-month cost

Over twelve months the totals are $2,388 for Noom Med and $2,148 for Gala GLP-1. Gala GLP-1 is lower by $240 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.

Dose policy

Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.

Membership fee

Neither charges a separate membership fee.

Shipping

Shipping is handled the same way by both — included in the quoted price.

What each record says

Noom Med Official site

Noom bundles its behavior program with medication access; compounded semaglutide lists at $199/month all-in.

It names its compounding pharmacy — Partner pharmacies, recorded as Partner network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Program-based; cancellation is Per plan terms; availability is stated as Most US states.

Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — noom.com program page capture 2026-08-08

Watch: Noom's program bundling changes frequently; confirm what the quoted figure includes.

Gala GLP-1 Official site

Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149.

It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacies (not named publicly), so who actually makes the medication cannot be independently verified; commitment terms are 3-month plan or standard monthly; confirm exact terms at enrollment; cancellation is Per provider terms; availability is stated as All 50 states (per provider claim; confirm at intake).

Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, capture 2026-07-14

Watch: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.

Which molecules each one carries

Noom Med carries semaglutide at $199 a month; does not offer tirzepatide.

Gala GLP-1 carries tirzepatide at $179 a month and semaglutide at $179 a month.

Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.

What neither record tells you

Noom Med does not publish

  • no published twelve-month semaglutide rate
  • no state-by-state availability list — it says Most US states
  • no specific cancellation or refund terms

Gala GLP-1 does not publish

  • no published twelve-month semaglutide rate
  • no named compounding pharmacy
  • no state-by-state availability list — it says All 50 states (per provider claim; confirm at intake)
  • no specific cancellation or refund terms

Ask Noom Med and Gala GLP-1 for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.

What would change this answer

Evidence may be upgraded. Gala GLP-1 carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.

Which one suits which reader

On the lowest standing monthly rate for semaglutide, Gala GLP-1 Official site wins this matchup. And if you would rather trust a better-evidenced number, noom med's price rests on stronger provenance.

Both figures should be checked at the provider's own checkout before you pay. Noom Med's semaglutide price is provider-stated as of 2026-08-08; Gala GLP-1's is reported as of 2026-07-14.

Questions

Is Noom Med or Gala GLP-1 cheaper for semaglutide?

Gala GLP-1 is cheaper on all-in monthly cost at 2.4 mg/week: $179 against $199, a difference of $20 a month. All-in means the medication plus every mandatory recurring fee.

What is the twelve-month cost of Noom Med versus Gala GLP-1?

Noom Med works out to $2,388 across twelve months and Gala GLP-1 to $2,148, on the plan terms each publishes.

Does Noom Med or Gala GLP-1 raise the price as the dose goes up?

Noom Med: no, it charges one flat rate at every dose. Gala GLP-1: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.

How many ways do Noom Med and Gala GLP-1 differ?

5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.

Which of Noom Med and Gala GLP-1 names its pharmacy?

Noom Med does — Partner pharmacies. Gala GLP-1 does not, recording only Partner 503A pharmacies (not named publicly), so who makes its medication cannot be independently verified.

How well evidenced are the Noom Med and Gala GLP-1 prices?

Noom Med's semaglutide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-08. Gala GLP-1's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.

Official sources: Noom Med official site · Gala GLP-1 official site. Compounded tirzepatide and semaglutide are not FDA-approved products.